[{"image":"https://icons.cdn.biorender.com/w75xh75/5f6ba15c5a7b5a0028d96f53/5f6ba0855a7b5a0028d96f46.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f6ba15c5a7b5a0028d96f53/5f6ba0855a7b5a0028d96f46.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f6ba15c5a7b5a0028d96f52/5f6ba0855a7b5a0028d96f46.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f6ba15c5a7b5a0028d96f52/5f6ba0855a7b5a0028d96f46.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f6ba15c5a7b5a0028d96f51/5f6ba0855a7b5a0028d96f46.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f6ba15c5a7b5a0028d96f51/5f6ba0855a7b5a0028d96f46.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f6ba15c5a7b5a0028d96f50/5f6ba0855a7b5a0028d96f46.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f6ba15c5a7b5a0028d96f50/5f6ba0855a7b5a0028d96f46.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f6ba15c5a7b5a0028d96f4f/5f6ba0855a7b5a0028d96f46.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f6ba15c5a7b5a0028d96f4f/5f6ba0855a7b5a0028d96f46.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f6ba15c5a7b5a0028d96f4e/5f6ba0855a7b5a0028d96f46.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f6ba15c5a7b5a0028d96f4e/5f6ba0855a7b5a0028d96f46.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f6ba15c5a7b5a0028d96f4d/5f6ba0855a7b5a0028d96f46.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f6ba15c5a7b5a0028d96f4d/5f6ba0855a7b5a0028d96f46.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f6ba15c5a7b5a0028d96f4c/5f6ba0855a7b5a0028d96f46.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f6ba15c5a7b5a0028d96f4c/5f6ba0855a7b5a0028d96f46.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f6ba15c5a7b5a0028d96f4b/5f6ba0855a7b5a0028d96f46.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f6ba15c5a7b5a0028d96f4b/5f6ba0855a7b5a0028d96f46.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f6ba15c5a7b5a0028d96f4a/5f6ba0855a7b5a0028d96f46.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f6ba15c5a7b5a0028d96f4a/5f6ba0855a7b5a0028d96f46.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f6ba15c5a7b5a0028d96f49/5f6ba0855a7b5a0028d96f46.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f6ba15c5a7b5a0028d96f49/5f6ba0855a7b5a0028d96f46.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f6ba15c5a7b5a0028d96f48/5f6ba0855a7b5a0028d96f46.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f6ba15c5a7b5a0028d96f48/5f6ba0855a7b5a0028d96f46.png"}]